Linda Keene Solomon & Associates LLC – Trademark Portfolio
Entity Type: 16
Linda Keene Solomon & Associates LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include STEMBIOTIC COMMUNITIES. The owner is based in Sarasota, FL.
1496 Dorgali Drive
Sarasota, FL 34238
Showing of trademarks Trademarks
Trademark Classifications
Linda Keene Solomon & Associates LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Linda Keene Solomon & Associates LLC have?
Linda Keene Solomon & Associates LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Linda Keene Solomon & Associates LLC file in?
Linda Keene Solomon & Associates LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Linda Keene Solomon & Associates LLC's most well-known trademarks?
Linda Keene Solomon & Associates LLC's registered trademark portfolio includes well-known marks such as STEMBIOTIC COMMUNITIES. These are among 1 currently registered trademark in the portfolio.
What is Linda Keene Solomon & Associates LLC's trademark registration success rate?
Linda Keene Solomon & Associates LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.